bioMerieux S.A. (BIM) - Product Pipeline Analysis, 2016 Update

Date: April 27, 2016
Pages: 69
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B57860BA643EN
Leaflet:

Download PDF Leaflet

bioMerieux S.A. (BIM) - Product Pipeline Analysis, 2016 Update
Summary

bioMerieux S.A. (bioMerieux) designs, develops and manufactures diagnostic systems and reagents for physicians and biologists. The company offers diagnostic solutions such as instruments, reagents and software. bioMerieux products are used diagnosing and managing infectious diseases, cardiovascular diseases and targeted cancers. The company also provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for agri-food, cosmetics and pharmaceutical industries. The company conducts its operations through subsidiaries and a broad network of distributors. bioMerieux is a part of the Institut Merieux group and is headquartered in Marcy l’Etoile, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company bioMerieux S.A.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
bioMerieux S.A. Company Snapshot
bioMerieux S.A. Company Overview
bioMerieux S.A. Pipeline Products and Clinical Trials Overview
bioMerieux S.A. – Pipeline Analysis Overview
Business Description
Key Facts
bioMerieux S.A. - Major Products and Services
bioMerieux S.A. Pipeline Products by Development Stage
bioMerieux S.A. Clinical Trials by Trial Status
bioMerieux S.A. Pipeline Products Overview
Annexin A3 Prostate Cancer Marker
Annexin A3 Prostate Cancer Marker Product Overview
BRAF - Breast Cancer Diagnostic Kit
BRAF - Breast Cancer Diagnostic Kit Product Overview
Breast Cancer Index
Breast Cancer Index Product Overview
Breast Cancer Index Clinical Trial
CancerTARGET ID
CancerTARGET ID Product Overview
CancerTREATMENT ID
CancerTREATMENT ID Product Overview
CancerTYPE ID
CancerTYPE ID Product Overview
Companion Diagnostic Test - Hormone-Dependent Breast Cancer
Companion Diagnostic Test - Hormone-Dependent Breast Cancer Product Overview
Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor
Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor Product Overview
Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor
Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor Product Overview
Companion Diagnostic Test - Hormone-Dependent Prostate Cancer
Companion Diagnostic Test - Hormone-Dependent Prostate Cancer Product Overview
Diagnostic Assay - Prostate Cancer
Diagnostic Assay - Prostate Cancer Product Overview
Diagnostic Test - Colorectal Cancer
Diagnostic Test - Colorectal Cancer Product Overview
Diagnostic Test - Tuberculosis
Diagnostic Test - Tuberculosis Product Overview
FilmArray Biothreat-E Test
FilmArray Biothreat-E Test Product Overview
FilmArray Direct Sepsis Panel
FilmArray Direct Sepsis Panel Product Overview
FilmArray Meningitis Panel
FilmArray Meningitis Panel Product Overview
FilmArray Pneumonia Pathogen Panel
FilmArray Pneumonia Pathogen Panel Product Overview
FilmArray STD Panel
FilmArray STD Panel Product Overview
FilmArray Torch
FilmArray Torch Product Overview
iMAG
iMAG Product Overview
Magnotech System
Magnotech System Product Overview
Magnotech System - Cardiovascular Disease Assay
Magnotech System - Cardiovascular Disease Assay Product Overview
NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test
NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test Product Overview
NucliSENS EasyQ Legionella spp Molecular Test
NucliSENS EasyQ Legionella spp Molecular Test Product Overview
NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test
NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test Product Overview
Screening Biomarker Assay - Prostate Cancer
Screening Biomarker Assay - Prostate Cancer Product Overview
VIDAS CRP Assay
VIDAS CRP Assay Product Overview
bioMerieux S.A. - Key Competitors
bioMerieux S.A. - Key Employees
bioMerieux S.A. - Key Employee Biographies
bioMerieux S.A. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
bioMerieux S.A., Recent Developments
Apr 20, 2016: bioMérieux – First-Quarter 2016 Business Review
Apr 19, 2016: Biotheranostics to Present Feasibility Data of Gene Expression Profiling in Blood
Apr 08, 2016: FilmArray Torch is now FDA cleared with all 4 existing FilmArray Panels and the system gets CE marked
Mar 22, 2016: bioMérieux and COPAN announce the first commercial success of their collaboration for the automation and efficiency of microbiology laboratories
Mar 02, 2016: bioMerieux – 2015 Financial Results
Jan 26, 2016: BioFire’s FilmArray Meningitis/Encephalitis Panel Gets CE Marked
Jan 21, 2016: bioMerieux – Fourth-Quarter 2015 Business Review
Jan 12, 2016: BioFire Submits Special 510(k) Application to the FDA for the use of FilmArray Torch, the New High Throughput FilmArray System with FilmArray Respiratory Panel
Dec 14, 2015: bioMerieux and Illumina announce the launch of bioMerieux EpiSeq, a revolutionary Next-Generation Sequencing service for epidemiological monitoring of bacterial infections
Dec 08, 2015: Studies Demonstrate Broadening Clinical Utility of bioTheranostics’ Breast Cancer Index Molecular Test in the Extended Endocrine Therapy Setting
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

bioMerieux S.A. Pipeline Products and Clinical Trials Overview
bioMerieux S.A. Pipeline Products by Equipment Type
bioMerieux S.A. Pipeline Products by Indication
bioMerieux S.A. Clinical Trials by Trial Status
bioMerieux S.A., Key Facts
bioMerieux S.A., Major Products and Services
bioMerieux S.A. Number of Pipeline Products by Development Stage
bioMerieux S.A. Pipeline Products Summary by Development Stage
bioMerieux S.A. Clinical Trials by Trial Status
bioMerieux S.A. Clinical Trials Summary
Annexin A3 Prostate Cancer Marker - Product Status
Annexin A3 Prostate Cancer Marker - Product Description
BRAF - Breast Cancer Diagnostic Kit - Product Status
BRAF - Breast Cancer Diagnostic Kit - Product Description
Breast Cancer Index - Product Status
Breast Cancer Index - Product Description
Breast Cancer Index - BioTheranostics Breast Cancer IndexSM Molecular Test Identifies Risk for Early and Late Breast Cancer Recurrence, Lancet Oncology Study Finds: A Prospective Randomized Trial
Breast Cancer Index - Clinical Utilization of Breast Cancer Index (BCI), a Gene Expression-based Assay for Prediction of Late Recurrence and Benefit from Extended Endocrine Therapy
CancerTARGET ID - Product Status
CancerTARGET ID - Product Description
CancerTREATMENT ID - Product Status
CancerTREATMENT ID - Product Description
CancerTYPE ID - Product Status
CancerTYPE ID - Product Description
Companion Diagnostic Test - Hormone-Dependent Breast Cancer - Product Status
Companion Diagnostic Test - Hormone-Dependent Breast Cancer - Product Description
Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor - Product Status
Companion Diagnostic Test - Hormone-Dependent Neuro Endocrine Tumor - Product Description
Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor - Product Status
Companion Diagnostic Test - Hormone-Dependent Pituitary Tumor - Product Description
Companion Diagnostic Test - Hormone-Dependent Prostate Cancer - Product Status
Companion Diagnostic Test - Hormone-Dependent Prostate Cancer - Product Description
Diagnostic Assay - Prostate Cancer - Product Status
Diagnostic Assay - Prostate Cancer - Product Description
Diagnostic Test - Colorectal Cancer - Product Status
Diagnostic Test - Colorectal Cancer - Product Description
Diagnostic Test - Tuberculosis - Product Status
Diagnostic Test - Tuberculosis - Product Description
FilmArray Biothreat-E Test - Product Status
FilmArray Biothreat-E Test - Product Description
FilmArray Direct Sepsis Panel - Product Status
FilmArray Direct Sepsis Panel - Product Description
FilmArray Meningitis Panel - Product Status
FilmArray Meningitis Panel - Product Description
FilmArray Pneumonia Pathogen Panel - Product Status
FilmArray Pneumonia Pathogen Panel - Product Description
FilmArray STD Panel - Product Status
FilmArray STD Panel - Product Description
FilmArray Torch - Product Status
FilmArray Torch - Product Description
iMAG - Product Status
iMAG - Product Description
Magnotech System - Product Status
Magnotech System - Product Description
Magnotech System - Cardiovascular Disease Assay - Product Status
Magnotech System - Cardiovascular Disease Assay - Product Description
NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test - Product Status
NucliSENS EasyQ Chlamydia Pneumoniae Molecular Test - Product Description
NucliSENS EasyQ Legionella spp Molecular Test - Product Status
NucliSENS EasyQ Legionella spp Molecular Test - Product Description
NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test - Product Status
NucliSENS EasyQ Mycoplasma Pneumoniae Molecular Test - Product Description
Screening Biomarker Assay - Prostate Cancer - Product Status
Screening Biomarker Assay - Prostate Cancer - Product Description
VIDAS CRP Assay - Product Status
VIDAS CRP Assay - Product Description
bioMerieux S.A., Key Employees
bioMerieux S.A., Key Employee Biographies
bioMerieux S.A., Other Locations
bioMerieux S.A., Subsidiaries

LIST OF FIGURES

bioMerieux S.A. Pipeline Products by Equipment Type
bioMerieux S.A. Pipeline Products by Development Stage
bioMerieux S.A. Clinical Trials by Trial Status
Skip to top


Ask Your Question

bioMerieux S.A. (BIM) - Product Pipeline Analysis, 2016 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: